Xiansi Zhao
Papers
1
Total Citations
11
H-Index
1
About
Xiansi Zhao has made significant contributions to the advancement of high-throughput screening technologies in antibody development and therapeutic discovery. Their key research areas center on flow cytometry automation, high-content screening, and the optimization of sample preparation workflows to overcome traditional bottlenecks in drug development pipelines. Zhao’s most notable work, "Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development" (2018, 11 citations), addresses a critical challenge: the labor-intensive sample preparation that historically limited flow cytometry’s utility as a primary screening method, despite its superior sensitivity and accuracy. By developing an automated system, Zhao enabled the rapid, high-content analysis of antibody candidates, directly supporting the growing demand for therapeutic antibodies in drug discovery. This innovation not only enhances throughput but also maintains the precision essential for identifying promising leads. Zhao’s research bridges the gap between traditional flow cytometry and modern high-throughput demands, offering a scalable solution that accelerates the early stages of antibody development. Their work stands as a practical tool for researchers seeking to streamline screening processes, demonstrating a clear impact on the efficiency and scope of therapeutic antibody discovery.
Research Focus
Key Achievements
Top Papers
- 1